Healthcare professionals are asked to report any suspected adverse reactions. Adverse events should be reported. For healthcare professionals: You can report such incidents to Roche directly by emailing ireland.drug_surveillance_centre@roche.com or calling +353 (0)1-4690700
▼ This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse reactions.
▼ This item needs to be read along with the Summary of Product Characteristics and additional Risk Minimisation Material, namely the ‘Columvi (glofitamab) Healthcare Professional Guide’ and ‘Columvi (glofitamab) Patient Card’ these can be found on Medicines.ie
To request information about a Roche Product, get in contact with Roche Medical Information experts who will be pleased to answer your question.Email: ireland.druginfo@roche.com
Tel: +353 (0)1-4690700 ext 4 Send us your request by webform
Please note that Roche can not advise on medical treatments of individuals. The attending physician is responsible for all decisions related to the prescribing of medication and medical treatment of the patient.
Marketing Authorisation Holder: Roche Registration GmbH, EmilBarell-Strasse 1, 79639 Grenzach-Wyhlen, Germany. Polivy®is a registered trademarks.